We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.29B
AUM Growth
+$890M
Cap. Flow
+$701M
Cap. Flow %
16.33%
Top 10 Hldgs %
8.17%
Holding
711
New
93
Increased
328
Reduced
163
Closed
47

Sector Composition

Rank Sector Weight
1 Industrials 21.37%
2 Financials 18.28%
3 Technology 12.45%
4 Healthcare 11.93%
5 Consumer Discretionary 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WT icon
626
WisdomTree
WT
$3.31B
$247K 0.01%
+35,954
New +$240K
ESNT icon
627
Essent Group
ESNT
$6.31B
$239K 0.01%
5,104
RBC icon
628
RBC Bearings
RBC
$17.7B
$231K 0.01%
1,062
GMED icon
629
Globus Medical
GMED
$11.4B
$227K 0.01%
3,810
+40
+1% +$2.28K
GPRE icon
630
Green Plains
GPRE
$1.06B
$226K 0.01%
+7,021
New +$222K
TNL icon
631
Travel + Leisure Co
TNL
$4.51B
$224K 0.01%
5,548
MTH icon
632
Meritage Homes
MTH
$4.7B
$219K 0.01%
+3,082
New +$193K
UPLD icon
633
Upland Software
UPLD
$14.3M
$217K 0.01%
6,027
SNPS icon
634
Synopsys
SNPS
$80.1B
$210K ﹤0.01%
+482
New +$194K
ATNM icon
635
Actinium Pharmaceuticals
ATNM
$24.3M
$206K ﹤0.01%
27,778
-18,533
-40% -$158K
BJ icon
636
BJs Wholesale Club
BJ
$12.3B
$205K ﹤0.01%
3,250
AOUT icon
637
American Outdoor Brands
AOUT
$161M
$205K ﹤0.01%
+23,588
New +$196K
ONCT
638
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$203K ﹤0.01%
29,368
SCL icon
639
Stepan Co
SCL
$1.47B
$200K ﹤0.01%
2,096
-42
-2% -$3.99K
DOUG icon
640
Douglas Elliman
DOUG
$165M
$196K ﹤0.01%
88,259
+19,500
+28% +$53.5K
KRON
641
DELISTED
Kronos Bio
KRON
$183K ﹤0.01%
106,496
+90,472
+565% +$144K
BMTX
642
DELISTED
BM Technologies, Inc.
BMTX
$181K ﹤0.01%
+60,876
New +$184K
AGEN
643
Agenus
AGEN
$285M
$149K ﹤0.01%
4,667
+3,952
+553% +$126K
PWP icon
644
Perella Weinberg Partners
PWP
$1.25B
$126K ﹤0.01%
+15,091
New +$125K
NSTG
645
DELISTED
NanoString Technologies, Inc.
NSTG
$116K ﹤0.01%
+28,603
New +$211K
AIRG icon
646
Airgain
AIRG
$72.4M
$101K ﹤0.01%
+18,651
New +$104K
BCAB icon
647
BioAtla
BCAB
$5.87M
$87.2K ﹤0.01%
+581
New +$99.9K
AFMD
648
DELISTED
Affimed
AFMD
$72.9K ﹤0.01%
12,179
PDSB icon
649
PDS Biotechnology
PDSB
$40.7M
$51.3K ﹤0.01%
+10,198
New +$66.8K
AA icon
650
Alcoa
AA
$13.6B
-40,358
Closed -$1.72M

Similar funds

Kennedy Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Kennedy Capital Management held 711 positions worth $4.29B, up 26% from $3.4B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Kennedy Capital Management deployed $701M of net new capital in Q2 2023, opening 93 new positions and adding to 328 existing holdings. Its largest new stake was Phathom Pharmaceuticals: 1,049,675 shares worth $15M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Addus HomeCare, an estimated $8.45M trimmed.

  • Kennedy Capital Management's largest Q2 2023 buy was Phathom Pharmaceuticals: 1,049,675 shares worth $15M.
  • Kennedy Capital Management added most to Banc of California in Q2 2023, an estimated $13.6M increase.
  • Kennedy Capital Management's biggest Q2 2023 reduction was Addus HomeCare, cutting an estimated $8.45M.
  • Kennedy Capital Management fully exited Ollie's Bargain Outlet in Q2 2023, selling an estimated $18.2M.
  • Kennedy Capital Management's ten largest holdings make up 8.2% of its $4.29B portfolio in Q2 2023.
  • Kennedy Capital Management opened 93 new positions and closed 47 in Q2 2023.
  • Kennedy Capital Management's portfolio value rose 26% quarter-over-quarter to $4.29B.

Based on Kennedy Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.